Patient Guide: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 40 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06453213
Status: 🟢 Enrolling Now
Condition: Focal Onset Seizure
Phase: PHASE4

Where You Can Participate

This study is available at 40 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Tucson, Arizona
  • • Little Rock, Arkansas
  • • And 37 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy - Join Clinical Trial NCTNCT06453213

How to Join This Clinical Trial - NCTNCT06453213

Learn how to participate in this PHASE4 trial studying an investigational therapy for Focal Onset Seizure. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Focal Onset Seizure. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Focal Onset Seizure
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06453213 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 40 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85032 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85718 - United States

Status: RECRUITING

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: RECRUITING

Clinical Research Site

Downey, California 90242 - United States

Status: RECRUITING

Clinical Research Site

Fresno, California 93710 - United States

Status: RECRUITING

Clinical Research Site

Newport Beach, California 92663 - United States

Status: RECRUITING

Clinical Research Site

Hartford, Connecticut 06102 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06519 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20037 - United States

Status: RECRUITING

Clinical Research Site

Kissimmee, Florida 34741 - United States

Status: RECRUITING

And 30 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Focal Onset Seizure:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships